RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTRIC, PHASE IIA CLINICAL TRIAL FOR EVALUATING THE SAFETY, TOLERABILITY, AND THERAPEUTIC EFFICACY OF DAILY ORAL ADMINISTRATION OF NFX88 TO TREAT NEUROPATHIC PAIN IN INDIVIDUALS WITH SPIN

Escribá PV, Gil-Agudo ÁM, Vidal Samsó J, Sánchez-Raya J, Salvador-de la Barrera S, Soto-León V, León-Álvarez N, Méndez Ferrer B, Membrilla-Mesa MD, Redondo Galán C, Benito-Penalva J, Montoto-Marqués A, Medel Rebollo J, Palazón García R, Gutiérrez Henares F, Miralles M, Torres M, Nieto-Librero AB, García Marco D, Gómez C, Jimeno D, Oliviero A.